Volume | 66,583 |
|
|||||
News | - | ||||||
Day High | 1.04 | Low High |
|||||
Day Low | 0.99 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Talphera Inc | TLPH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.03 | 0.99 | 1.04 | 1.02 | 1.02 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
253 | 66,583 | $ 1.03 | $ 68,275 | - | 0.72 - 1.61 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:33 | 1 | $ 1.04 | USD |
Talphera Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.48M | 16.97M | - | 651k | -18.4M | -1.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Talphera News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLPH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.08 | 1.10 | 0.9734 | 1.01 | 44,530 | -0.06 | -5.56% |
1 Month | 1.12 | 1.24 | 0.92 | 1.08 | 72,199 | -0.10 | -8.93% |
3 Months | 0.84 | 1.61 | 0.84 | 1.17 | 98,117 | 0.18 | 21.43% |
6 Months | 0.86 | 1.61 | 0.72 | 1.10 | 113,518 | 0.16 | 18.60% |
1 Year | 0.86 | 1.61 | 0.72 | 1.10 | 113,518 | 0.16 | 18.60% |
3 Years | 0.86 | 1.61 | 0.72 | 1.10 | 113,518 | 0.16 | 18.60% |
5 Years | 0.86 | 1.61 | 0.72 | 1.10 | 113,518 | 0.16 | 18.60% |
Talphera Description
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. |